checkAd
    Startseite > Aktien > Alto Neuroscience > Nachrichten
    Alto Neuroscience Aktie
    12,470
     
    USD
    -2,73 %
    -0,350 USD
    Letzter Kurs 02:04:00 NYSE
    12,450
     
    USD
    1.100 STK
    Geldkurs 17.05.24
    12,490
     
    USD
    200 STK
    Briefkurs 17.05.24
    ISIN: US02157Q1094 · WKN: A401D8 · SYM: ANRO · USA

    Neueste Nachrichten

    Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights
    14.05.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
    09.05.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
    23.04.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive Disorder
    03.04.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
    21.03.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors
    11.03.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience to Participate in Upcoming Investor Conferences
    07.03.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference
    27.02.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    06.02.24 · Business Wire (engl.) · Alto Neuroscience
    Alto Neuroscience Announces Pricing of Upsized Initial Public Offering
    02.02.24 · Business Wire (engl.) · Alto Neuroscience